StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Done loading up.

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Mar 25, 2021 1:42pm

148 Views

Post# 32876400

RE:Done loading up.

SAGDollar wrote: Loaded heavy and ready for launch. Aristotle will be launched in Q1 2021. That says it all.

Yes, after the statements made on its rollout, if there was a change or delay then there would have been an NR on that. Anybody's guess on the date at this point.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale